10th Edition of The International Pharmacopoeia

The International Pharmacopoeia (Ph. Int.) contains recommended procedures for analysis and specifications for pharmaceutical substances (active pharmaceutical ingredients, APIs) and dosage forms. According to the WHO (World Health Organization) it is intended to serve as source for reference or adaptation by any WHO Member State. The Ph. Int. has legal status, whenever a national or regional authority refers to it in appropriate legislation.

Compared to other pharmacopoeias (e.g. Ph. Eur., USP, JP), "priority is given to medicines included in the WHO Model List of Essential Medicines and to medicines which are important for WHO health programmes and for which other pharmacopoeias do not offer any test specifications". Moreover, the needs of developing countries are taken into account.

The International Pharmacopoeia, Tenth Edition, 2020 - Content Overview

  • General Notices (includes information on storage, stability, labelling, identity, tests & assays, accuracy and precision, calculation of results, impurities, reference substances, etc.)
  • Appendices to the General Notices
    Abbreviations and symbols
    Units of measurement
    Names, symbols, and relative atomic masses of certain elements
  • Monographs
    Pharmaceutical substances
    Dosage forms
    Radiopharmaceuticals
  • Methods of Analysis
    1. Physical and Physicochemical Methods
    2. Chemical methods
    3. Biological methods
    4. Methods for materials of plant origin
    5. Pharmaceutical technical procedures
  • Infrared reference spectra
  • Reagents, test solutions and volumetric solutions
  • Supplementary information

The International Pharmacopoeia is available online free for use.

Conference Recommendations

GMP meets GCP - Live Online


29-31 March 2022

GMP meets GCP - Live Online

Go back

GMP Conferences by Topics